Data / Form D filings / XENTER, INC.
XENTER, INC.: Form D filings
XENTER, INC., a biotechnology company in Draper, UT, filed 4 Form D notices with the SEC between 2021 and 2023. The latest, on January 6, 2023, reports $1.1 million sold of a $40 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 344 WEST 13800 SOUTH, STE. 400, Draper, UT, 84020
- Phone
- (385) 799-6400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1838073
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2023 | New notice | $40,000,000 | $1,131,800 | $38,868,200 | 12 | Dec 23, 2022 | sec.gov |
| Jan 6, 2023 | Amendment | $20,000,000 | $19,595,500 | $404,500 | 79 | Jun 30, 2021 | sec.gov |
| Jul 14, 2021 | New notice | $10,000,000 | $1,000,000 | $9,000,000 | 1 | Jun 30, 2021 | sec.gov |
| Jan 8, 2021 | New notice | $12,000,000 | $2,803,712 | $9,196,288 | 22 | Dec 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JAMES TOBIN | Director | |
| ROBERT LANGER | Director | |
| ELAZER EDELMAN | Director | |
| RICHARD LINDER | Executive Officer, Director | |
| MARK STAUTBERG | Director | |
| ERIC PEARSON | Executive Officer | |
| ROBERT BAXTER | Executive Officer, Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what XENTER, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.